IN2013MU02905A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02905A IN2013MU02905A IN2905MU2013A IN2013MU02905A IN 2013MU02905 A IN2013MU02905 A IN 2013MU02905A IN 2905MU2013 A IN2905MU2013 A IN 2905MU2013A IN 2013MU02905 A IN2013MU02905 A IN 2013MU02905A
- Authority
- IN
- India
- Prior art keywords
- preparation
- improved process
- relates
- ethoxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/916,402 US10112898B2 (en) | 2013-09-06 | 2014-09-05 | Process for the preparation of saroglitazar pharmaceutical salts |
| PCT/IN2014/000584 WO2015033357A2 (en) | 2013-09-06 | 2014-09-05 | An improved process for the preparation of pyrrole derivatives |
| IN2905MU2013 IN2013MU02905A (en:Method) | 2013-09-06 | 2014-09-05 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2905MU2013 IN2013MU02905A (en:Method) | 2013-09-06 | 2014-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02905A true IN2013MU02905A (en:Method) | 2015-07-03 |
Family
ID=52023583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2905MU2013 IN2013MU02905A (en:Method) | 2013-09-06 | 2014-09-05 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US10112898B2 (en:Method) |
| IN (1) | IN2013MU02905A (en:Method) |
| WO (1) | WO2015033357A2 (en:Method) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2825456C (en) | 2011-01-31 | 2016-01-05 | Cadila Healthcare Limited | Treatment for lipodystrophy |
| CA2900435C (en) | 2013-04-22 | 2017-02-14 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| PH12015502667B1 (en) | 2013-05-30 | 2023-10-18 | Zydus Lifesciences Ltd | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (en:Method) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
| US10385017B2 (en) | 2015-10-14 | 2019-08-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| JP7547048B2 (ja) * | 2016-10-12 | 2024-09-09 | ボナファイド・ヘルス，エルエルシー | ピコリン酸マグネシウム組成物および使用方法 |
| ES2894261T3 (es) | 2016-12-09 | 2022-02-14 | Cadila Healthcare Ltd | Tratamiento de la colangitis biliar primaria |
| WO2020183379A1 (en) * | 2019-03-11 | 2020-09-17 | Cadila Healthcare Limited | Novel salts, crystalline forms and premix of hypolipidemic agent |
| US12201611B2 (en) * | 2020-07-24 | 2025-01-21 | Zydus Lifesciences Limited | Composition comprising high purity pyrrole derivative and method for preparation thereof |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| CA2139442A1 (en) | 1992-07-03 | 1994-01-20 | David Haigh | Heterocyclic compounds as pharmaceutical |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| KR100380875B1 (ko) | 1995-04-28 | 2003-10-10 | 다이이찌 세이야꾸 가부시기가이샤 | 펜타사이클릭화합물 |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| WO1999016758A1 (en) | 1997-10-27 | 1999-04-08 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| WO1999008501A2 (en) | 1998-04-23 | 1999-02-25 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| PL341795A1 (en) | 1998-05-27 | 2001-05-07 | Reddy Research Foundation | Bicycle compounds, process for obtaining them and pharmacological compositions containing such compounds |
| AU6325899A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
| WO2000023445A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| WO2000023451A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| DK1250323T3 (da) | 2000-01-19 | 2014-02-03 | Cadila Healthcare Ltd | Forbindelser med hypolipidemiske og hypokolesterolemiske virkninger, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| AU2001286163A1 (en) | 2000-09-22 | 2002-04-02 | Dr. Reddy's Research Foundation | An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| US6514995B1 (en) | 2000-09-25 | 2003-02-04 | Advanced Research And Technology Institute, Inc. | Enediyne compounds and methods related thereto |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US20070051626A1 (en) | 2003-09-26 | 2007-03-08 | Chiho Itou | Cataphoresis apparatus cataphoresis method, and detection method for organism-related material using the apparatus and the method |
| KR101071390B1 (ko) | 2004-03-15 | 2011-10-07 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
| EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| PT2641596T (pt) | 2009-11-26 | 2018-07-31 | Genfit | Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas |
| BR112013008985A2 (pt) | 2010-10-12 | 2016-07-05 | Cerecor Inc | composições antitussígenas compreendendo memantina |
| CA2825456C (en) | 2011-01-31 | 2016-01-05 | Cadila Healthcare Limited | Treatment for lipodystrophy |
| CA2900435C (en) | 2013-04-22 | 2017-02-14 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| PH12015502667B1 (en) | 2013-05-30 | 2023-10-18 | Zydus Lifesciences Ltd | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (en:Method) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US9951009B2 (en) | 2013-08-29 | 2018-04-24 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
| US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
-
2014
- 2014-09-05 US US14/916,402 patent/US10112898B2/en active Active
- 2014-09-05 WO PCT/IN2014/000584 patent/WO2015033357A2/en not_active Ceased
- 2014-09-05 IN IN2905MU2013 patent/IN2013MU02905A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015033357A3 (en) | 2015-05-07 |
| WO2015033357A2 (en) | 2015-03-12 |
| US10112898B2 (en) | 2018-10-30 |
| US20160194280A1 (en) | 2016-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MU02905A (en:Method) | ||
| PH12020551628A1 (en) | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities | |
| PH12013500870A1 (en) | Heterocyclic compounds and uses thereof | |
| MY150542A (en) | Cmet inhibitors | |
| PH12012500674A1 (en) | Heterocyclic compounds useful as pdk1 inhibitors | |
| SMT201300098B (it) | Forme solide di N-(4-(7-azabiciclo[2.2.1]eptan-7-il)-2-(trifluorometil)fenil-4-osso-5-trifluorometil)-1,4-diidrochinolina-3-carbossammide | |
| TN2011000673A1 (en) | Bace inhibitors | |
| CL2014001765A1 (es) | Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina. | |
| WO2013098833A3 (en) | Processes and intermediates for preparing rivaroxaban | |
| MX353578B (es) | Dihidrodiazpinocarbazolonas tetra o penta-ciclicas fusionadas como inhibidores de poli (adp-ribosa) polimerasa (parp). | |
| UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
| HUE041725T2 (hu) | (S)-1-(2-hidroxietil)-4-metil-N-[4-(metilszulfonil)fenil]-5-[2-(trifluormetil)fenil]-1H-pirrol-3-karboxamid kristálya | |
| EA201590552A1 (ru) | Аминохинолины в качестве ингибиторов киназы | |
| MX2015017156A (es) | Inhibidores de bace. | |
| NZ742952A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| TW201613934A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| CL2013000797A1 (es) | Proceso de preparacion de (2r,3r)-3-{4-(s-(ciclo)alquil-sulfonimidoil)fenil}amino}-5-(trifluorometil)pirimidin-4-il}oxi}butan-2-2ol inhibidores; y los compuestos intermediarios considerados. | |
| IN2013MU03862A (en:Method) | ||
| MX2011006560A (es) | Derivados heterociclicos fucionados con oxadiazola utiles para el tratamiento de esclerosis multiple. | |
| WO2013175499A3 (en) | Process for the preparation of 5-(4-[4-(5-cyano-1 h-indol-3-yl)butyl]piperazin-1 -yl)benzofuran-2-carboxamide and intermediates thereof, polymorphic forms thereof | |
| IN2013MU00665A (en:Method) | ||
| EA201892370A1 (ru) | Замещенные конденсированные пиримидиноновые соединения | |
| BR112013003225A2 (pt) | composto de fórmula (i), ou sais, solvatos, ou hidratos do mesmo, composição farmacêutica e método para preparar o composto | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
| EA201301136A3 (ru) | Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей |